Skip to main content

GM Mosquito Cuts Wild-Type Numbers

Release of a transgenic version of Aedes aegypti, a species that can carry dengue virus, decimated a local population of non-mutated mosquitoes, according to a study.

Written byKerry Grens
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00

FREESTOCKPHOTOS.BIZ, CDC/PROF FRANK HADLEY COLLINSA genetically modified (GM) mosquito—designed to infiltrate a wild population and produce offspring that die before reproductive age—has devastated local mosquito numbers in a field trial in Brazil. Researchers reported in PLOS Neglected Tropical Diseases this month (July 2) that one year after deployment of the mutant Aedes aegypti, mosquito numbers were reduced 80 percent to 95 percent.

“The fact that the number of Aedes aegypti adults were reduced by 95% in the treatment area confirms that the Oxitec mosquito does what it is supposed to and that is to get rid of mosquitoes,” study coauthor Andrew McKemey, head of field operations at Oxitec, which developed the GM mosquito, said in a press release.

Aedes aegypti can carry pathogens that cause diseases, including dengue and chikungunya. Although McKemey’s study did not determine whether disease burden among humans would drop with the introduction of GM mosquitoes, he said in the statement that “according to published mathematical models reviewed and recommended by the World Health Organization (WHO) working group on dengue, it would . . . reduce the number of biting mosquitoes below the disease ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

  • kerry grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

    View Full Profile

Related Topics

Related articles background image
The Scientist Digest cover September 2026
September 2026

Multiplex Microscopy Becomes Easier with Encoded Antibodies

A new system that enables researchers to uniquely tag monoclonal antibodies for use in microscopy could help simplify complex imaging studies.

View this Issue
Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Alamar Biosciences logo
Best Practices for qPCR Assay Design and Optimization

Best Practices for qPCR Assay Design and Optimization

Bio-Rad
Beyond the Basics: Strategies for Single-Cell and Spatial Transcriptomics Analysis

Beyond the Basics: Strategies for Single-Cell and Spatial Transcriptomics Analysis

bioxcell
Scientist reviewing cellular and molecular data on a computer in a laboratory.

Building Translation-Ready Biomarkers with Connected Workflows

Danaher Logo

Products

Closeup image of a multi channel pipette dispensing pink liquid into a 96-well plate.

The ASSIST PLUS pipetting robot for affordable workflow automation

Integra Logo
Single cells in suspension

Rapidly isolate primary cells and make uniform single-cell suspensions with Corning® Cell Strainers

Corning logo
Abstract image representing cell membranes linked together.

CellBrite® Steady Membrane Stain: Cell surface staining built for real-time imaging

Biotium
sino biological logo

Monod Bio Licenses AI-designed Protein Technologies to SignalChem Biotech for Custom Discovery Assays